Pentwater Capital Management’s Pfizer PFE Stock Holding History

Pentwater Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-210,800	Closed	-$7.1M	–	127
2018 Q1	$7.1M	Buy	+210,800	New	+$7.25M	0.05%	67
2017 Q4	–	Sell	-3,372,800	Closed	-$114M	–	101
2017 Q3	$114M	Sell	3,372,800 -1,812,880	-35%	-$58.3M	0.98%	20
2017 Q2	$165M	Sell	5,185,680 -177,072	-3%	-$5.58M	1.52%	19
2017 Q1	$174M	Sell	5,362,752 -132,699	-2%	-$4.18M	2.13%	16
2016 Q4	$169M	Buy	5,495,451 +737,800	+16%	+$22.5M	2.17%	10
2016 Q3	$153M	Sell	4,757,651 -1,250,149	-21%	-$41.8M	1.42%	17
2016 Q2	$201M	Sell	6,007,800 -3,162,000	-34%	-$101M	2.68%	11
2016 Q1	$258M	Buy	9,169,800 +8,115,800	+770%	+$232M	1.89%	16
2015 Q4	$32.3M	Buy	+1,054,000	New	+$33.2M	0.22%	44
2014 Q3	–	Sell	-189,720	Closed	-$5.34M	–	191
2014 Q2	$5.34M	Buy	+189,720	New	+$5.41M	0.06%	106

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pentwater Capital Management's PFE Position: Q1 2018 in Review

Pentwater Capital Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 20,869 shares — an estimated $717K sold.

Pentwater Capital Management first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $765M in Q2 2013. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Pentwater Capital Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Pentwater Capital Management sold 20,869 Pfizer shares in Q1 2018, an estimated $717K.
Pentwater Capital Management first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
Pentwater Capital Management's Pfizer position peaked at $765M in Q2 2013.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Pentwater Capital Management's 13F filing for Q1 2018, filed 15 May 2018.